Lee, Richel E.

HRN: 26-81-47  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2025
CEFTRIAXONE 1G (VIAL)
08/03/2025
08/10/2025
IV
2g
OD
Cholecystolithiasis
Remove - Pending Acceptance
08/03/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/03/2025
08/10/2025
IV
500mg
Q8h
Cholecystolithiasis
Remove - Pending Acceptance
08/03/2025
CEFUROXIME 1.5GM (VIAL)
08/04/2025
08/11/2025
IVTT
1.5g
1 Hr Prior To OR Then Q8 Thereafter
Cholecystolithiasis Not In Cholecystitis
Remove - Pending Acceptance
08/04/2025
CEFTRIAXONE 1G (VIAL)
08/04/2025
08/11/2025
IV
2g
OD
S/P OPEN CHOLECYSTECTOMY
Remove - Pending Acceptance
08/06/2025
METRONIDAZOLE 500MG (TAB)
08/06/2025
08/10/2025
PO
500mg
Q8h
Chronic Calculous Cholecystitis
Remove - Pending Acceptance
08/06/2025
METRONIDAZOLE 500MG (TAB)
08/06/2025
08/10/2025
ORAL
500mg
Q8H X 4 More Days
Open Cholecystectomy
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: